April 10, 2020
CHECK OUT OUR APRIL ISSUE
View the
latest issue
online.
Genetic testing’s role centers on advanced prostate cancer
In this interview, Leonard G. Gomella, MD, discusses the increasingly important role genetic testing plays in prostate cancer, current obstacles to testing, and when and how it will be carried out.
Learn more
COVID-19 and market fluctuation: What you should do
Avoid making decisions motivated by emotion and fear, advises Jeff Witz, CFP.
Get his advice
SURVEY
Is DRE still a relevant tool in the management of prostate cancer?
MORE FROM
UROLOGY TIMES:
Surveillance safe for patients with Grade Group 1 prostate Ca
Dealing with COVID-19: Readers weigh in